GEG vs ZYXI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEG is a Hold and ZYXI is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GEG’s FA Score shows that 0 FA rating(s) are green whileZYXI’s FA Score has 0 green FA rating(s).
- GEG’s FA Score: 0 green, 5 red.
- ZYXI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GEG’s TA Score shows that 3 TA indicator(s) are bullish while ZYXI’s TA Score has 5 bullish TA indicator(s).
- GEG’s TA Score: 3 bullish, 5 bearish.
- ZYXI’s TA Score: 5 bullish, 3 bearish.
Price Growth
GEG (@Investment Managers) experienced а +0.79% price change this week, while ZYXI (@Medical Distributors) price change was -7.41% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -2.35%. For the same industry, the average monthly price growth was -3.23%, and the average quarterly price growth was -1.72%.
The average weekly price growth across all stocks in the @Medical Distributors industry was -3.83%. For the same industry, the average monthly price growth was -6.11%, and the average quarterly price growth was -9.26%.
Reported Earning Dates
GEG is expected to report earnings on May 08, 2025.
ZYXI is expected to report earnings on Apr 24, 2025.
Industries' Descriptions
@Investment Managers (-2.35% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
@Medical Distributors (-3.83% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
| GEG | ZYXI | GEG / ZYXI | |
| Capitalization | 60.7M | 398M | 15% |
| EBITDA | 2.4M | 17.9M | 13% |
| Gain YTD | 4.972 | -71.910 | -7% |
| P/E Ratio | 2.31 | 46.30 | 5% |
| Revenue | 11.1M | 184M | 6% |
| Total Cash | 123M | 44.6M | 276% |
| Total Debt | 64.4M | 76.2M | 85% |
GEG | ZYXI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 94 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 90 | 78 | |
PRICE GROWTH RATING 1..100 | 49 | 98 | |
P/E GROWTH RATING 1..100 | 97 | 88 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GEG's Valuation (56) in the Internet Software Or Services industry is somewhat better than the same rating for ZYXI (94) in the Medical Specialties industry. This means that GEG’s stock grew somewhat faster than ZYXI’s over the last 12 months.
GEG's Profit vs Risk Rating (100) in the Internet Software Or Services industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that GEG’s stock grew similarly to ZYXI’s over the last 12 months.
ZYXI's SMR Rating (78) in the Medical Specialties industry is in the same range as GEG (90) in the Internet Software Or Services industry. This means that ZYXI’s stock grew similarly to GEG’s over the last 12 months.
GEG's Price Growth Rating (49) in the Internet Software Or Services industry is somewhat better than the same rating for ZYXI (98) in the Medical Specialties industry. This means that GEG’s stock grew somewhat faster than ZYXI’s over the last 12 months.
ZYXI's P/E Growth Rating (88) in the Medical Specialties industry is in the same range as GEG (97) in the Internet Software Or Services industry. This means that ZYXI’s stock grew similarly to GEG’s over the last 12 months.
| GEG | ZYXI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | 1 day ago 86% |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 69% | 1 day ago 81% |
| MACD ODDS (%) | 1 day ago 71% | 1 day ago 75% |
| TrendWeek ODDS (%) | 1 day ago 70% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 70% | 1 day ago 79% |
| Advances ODDS (%) | 12 days ago 70% | 29 days ago 78% |
| Declines ODDS (%) | 9 days ago 77% | 1 day ago 80% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 69% |
| Aroon ODDS (%) | N/A | 1 day ago 82% |
GEG and
Correlation & Price change
A.I.dvisor tells us that GEG and PSEC have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GEG and PSEC's prices will move in lockstep.
| Ticker / NAME | Correlation To GEG | 1D Price Change % | ||
|---|---|---|---|---|
| GEG | 100% | N/A | ||
| PSEC - GEG | 23% Poorly correlated | +0.25% | ||
| CION - GEG | 23% Poorly correlated | -2.58% | ||
| VRTS - GEG | 22% Poorly correlated | -7.57% | ||
| STEP - GEG | 22% Poorly correlated | -11.45% | ||
| IVZ - GEG | 21% Poorly correlated | -11.85% | ||
More | ||||
ZYXI and
Correlation & Price change
A.I.dvisor tells us that ZYXI and OMI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYXI and OMI's prices will move in lockstep.
| Ticker / NAME | Correlation To ZYXI | 1D Price Change % | ||
|---|---|---|---|---|
| ZYXI | 100% | -7.79% | ||
| OMI - ZYXI | 28% Poorly correlated | -6.22% | ||
| HSIC - ZYXI | 20% Poorly correlated | -3.84% | ||
| PDCO - ZYXI | 14% Poorly correlated | -0.22% | ||
| GEG - ZYXI | 11% Poorly correlated | N/A | ||
| AMFPF - ZYXI | 10% Poorly correlated | N/A | ||
More | ||||